Publications by authors named "Thais de Maria Frota Vasconcelos"

Article Synopsis
  • SARS-CoV-2 infection can cause various neurological issues during both the acute and Long COVID phases, affecting cognition, sleep, smell, and mental health.
  • These symptoms are more frequently reported in young adults and women, and they can occur after both severe and mild cases of COVID-19.
  • The prevalence of neurological symptoms in Long COVID raises concerns due to significant health impacts and associated costs, estimated at around 3.7 trillion US dollars.
View Article and Find Full Text PDF

Background: Turner syndrome (TS) is a rare condition associated with a completely or partially missing X chromosome that affects 1 in 2500 girls. TS increases the risk of autoimmune diseases, including Graves' disease (GD). Moyamoya disease is a rare cerebral arteriopathy of unknown etiology characterized by progressive bilateral stenosis of the internal carotid artery and its branches.

View Article and Find Full Text PDF

Background: COVID-19 is a pandemic disease responsible for many deaths worldwide. Many neurological manifestations have been described. We report a case of normal pressure hydrocephalus (NPH) 2 months after acute COVID19 infection, in a patient without other risk factors.

View Article and Find Full Text PDF

SARS-COV-2 infection has affected millions of individuals with a wide range of clinical manifestations, including central and peripheral nervous systems through several mechanisms. A rare but potentially severe manifestation of this virus is transverse myelitis. Herein, we report on two patients who developed paraparesis, sensory deficit, and autonomic changes on the tenth day after infection by COVID-19.

View Article and Find Full Text PDF

Anti-GAD ataxia is one of the most common forms of immune-mediated cerebellar ataxias. Many neurological syndromes have been reported in association with anti-GAD. Ophthalmoparesis has been described in stiff person syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • Headache is a common symptom in COVID-19, affecting 6.5% to 34% of patients, but previous studies often included unverified cases or focused on severe cases.
  • The study analyzed 24 laboratory-confirmed COVID-19 patients who reported headaches, revealing that the average age was 53.8 years and most had no prior history of headaches.
  • The headaches were mainly bifrontal or holistic, of a pressure quality, typically began early in illness, and worsened with physical activity, but no unique characteristics were found to distinguish them from other headache causes.
View Article and Find Full Text PDF